Money Arthur G, Barnett Julie, Kuljis Jasna, Lucas Jane
Department of Information Systems and Computing, Brunel University, London, UK.
Scand J Caring Sci. 2013 Jun;27(2):335-44. doi: 10.1111/j.1471-6712.2012.01045.x. Epub 2012 Jul 27.
In recent years, government initiatives have proposed that patient self-care should serve as a key resource in response to the anticipated increase in global demand for health care. However, if patients are to be empowered as self-carers, barriers to engagement must be identified and overcome. Anaphylaxis is an increasingly common life-threatening allergic reaction. Patients at risk of anaphylaxis are prescribed epinephrine auto-injectors and play a crucial role in delivering their own care and management of this condition. One key recommendation is that patients routinely carry an epinephrine auto-injector with them and deploy the device when needed. However, only a small proportion of patients that require epinephrine actually receive it.
To explore the reasons why patients who have been prescribed epinephrine auto-injectors fail to adhere to self-care and management recommendations.
In-depth interviews with 15 adults who have been prescribed epinephrine auto-injectors were carried out to explore the barriers that exist in the provision of effective self-care and management of anaphylaxis.
Inconsistent health professional advice, perceived stigma of carrying a 'weapon-like' device, poor device design and limited patient training were identified as barriers to carriage or use. Patients were reluctant to carry devices in public because of perceived and observed stigma and suspicion. They were happy to ignore expiry dates, and some participants were confident that the emergency services would provide them with the appropriate care they needed, and therefore, did not carry the device in urban areas.
Improved training of patients, the public and health professionals around both the carriage and use of auto-injectors are areas for urgent attention if improved levels of self-care are to be attained. The design of epinephrine auto-injectors should also receive attention as patients often fail to carry them owing to size and aesthetics.
近年来,政府倡议提出患者自我护理应成为应对全球预期医疗保健需求增长的关键资源。然而,若要使患者成为自我护理者,必须识别并克服参与过程中的障碍。过敏反应是一种日益常见的危及生命的过敏反应。有过敏反应风险的患者会被开具肾上腺素自动注射器,且在自我护理和管理这种病症方面发挥着关键作用。一项关键建议是患者应常规随身携带肾上腺素自动注射器,并在需要时使用该设备。然而,实际需要肾上腺素的患者中只有一小部分真正获得了它。
探讨已被开具肾上腺素自动注射器的患者未遵守自我护理和管理建议的原因。
对15名已被开具肾上腺素自动注射器的成年人进行了深入访谈,以探究在提供有效的过敏反应自我护理和管理方面存在的障碍。
健康专业人员的建议不一致、携带“武器般”设备所感受到的污名、设备设计不佳以及患者培训有限被确定为携带或使用的障碍。由于感受到和观察到的污名及怀疑,患者不愿在公共场合携带设备。他们乐于忽略有效期,一些参与者坚信紧急服务会为他们提供所需的适当护理,因此在城市地区不携带该设备。
如果要提高自我护理水平,围绕自动注射器的携带和使用对患者、公众及健康专业人员进行更好的培训是亟待关注的领域。肾上腺素自动注射器的设计也应受到关注,因为患者常因尺寸和美观问题而不携带它们。